Bionano Genomics, Inc. (BNGO)
Data as of , from SEC Form 4 filings.
See up to 3 months of BNGO. The 7-day demo opens the 1M and 3M ranges and puts BNGO on your watchlist.
Start 7-day demoLatest BNGO insider trades
About Bionano Genomics, Inc. (BNGO)
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
- SAN DIEGO, CA
- 97
- 2018
- XNAS
BNGO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 8,000 | $10K |
| Grant or award | 4 | 89,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BNGO insider transactions (Form 4)
3030 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Albert Luderer - Officer | Open-market purchase | Common Stock | 4,000 | $1.21 | $5K | |
| Albert Luderer - Officer | Open-market purchase | Common Stock | 4,000 | $1.22 | $5K | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Mark Oldakowski - Officer | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Alex Reid Hastie - Officer | Grant or award | Stock Option (Right to Buy) | 54,000 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Tax withholding / forfeiture | Common Stock | 24 footnote F1 | $1.30 | $31 | |
| ||||||
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 27 footnote F1 | $1.30 | $35 | |
| ||||||
 Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 24 footnote F1 | $1.30 | $31 | |
| ||||||
| Mark Adamchak - Officer | Tax withholding / forfeiture | Common Stock | 7 footnote F1 | $1.30 | $9 | |
| ||||||
| Aleksandar Rajkovic | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Yvonne Linney | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Kristiina Md Vuori | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Christopher J. Twomey | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| David L. Barker | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 18 | $1.10 | $20 | |
| Mark Adamchak - Officer | Tax withholding / forfeiture | Common Stock | 3 | $1.10 | $3 | |
| Jonathan V. Dixon - Officer | Tax withholding / forfeiture | Common Stock | 6 | $1.10 | $7 | |
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 20 | $1.10 | $22 | |
 R. Erik Holmlin - Officer | Tax withholding / forfeiture | Common Stock | 51 | $1.10 | $56 | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 10,890 | $0.00 | - | |
| Alka Chaubey - Officer | Grant or award | Stock Option (Right to Buy) | 27,737 | $0.00 | - | |
| Mark Oldakowski - Officer | Grant or award | Stock Option (Right to Buy) | 27,737 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Grant or award | Stock Option (Right to Buy) | 26,117 | $0.00 | - | |
| R. Erik Holmlin - Officer | Grant or award | Stock Option (Right to Buy) | 69,484 | $0.00 | - | |
| Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 51 | $4.06 | $207 | |
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 59 | $4.06 | $240 | |
| Christopher J. Twomey - Director | Grant or award | Stock Option (Right to Buy) | 2,775 | $0.00 | - | |
| David L. Barker - Director | Grant or award | Stock Option (Right to Buy) | 2,775 | $0.00 | - | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 17,500 | $0.00 | - | |
BNGO insider trading FAQ
What is the latest insider trade for BNGO?
Bionano Genomics, Inc. (BNGO) had 6 insider filings in the last 90 days, with the most recent on 2026-09-09. The full record for BNGO runs to 30 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BNGO stock?
2 insider purchases of BNGO were filed in the last 90 days, totaling $10K.
How many insiders are selling BNGO stock?
No insider sales of BNGO were filed in the last 90 days.
Where can I see BNGO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BNGO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Albert Luderer view on EDGAR
- - Albert Luderer view on EDGAR
- - Mark Adamchak view on EDGAR
- - Jonathan V. Dixon view on EDGAR
- - Mark Oldakowski view on EDGAR
- - Alex Reid Hastie view on EDGAR
- - Jonathan V. Dixon view on EDGAR
- - Mark Oldakowski view on EDGAR
- - Alka Chaubey view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where BNGO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BNGO with a 7-day demo
- BNGO on your watchlist
- Every BNGO Form 4 filing on record
- Up to 3 months of BNGO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
